Intestinal dysbiosis augments liver disease progression via NLRP3 in a murine model of primary sclerosing cholangitis | Gut

Subscribe
Log In More

Log in via Institution
Log in via OpenAthens
Log in via BSG

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Latest content

Current issue

Archive

Authors

About
Subscribe
Log in More

Log in via Institution
Log in via OpenAthens
Log in via BSG

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals More

Article metrics

Hepatology

Original article

Intestinal dysbiosis augments liver disease progression via NLRP3 in a murine model of primary sclerosing cholangitis

Online download statistics by month:

Online download statistics by month: March 2019 to July 2021

	Abstract	Full	Pdf
Mar 2019	1673	280	176
Apr 2019	985	139	76
May 2019	656	104	56
Jun 2019	455	61	33
Jul 2019	798	157	93
Aug 2019	367	92	50
Sep 2019	329	103	70
Oct 2019	322	82	48
Nov 2019	376	109	44
Dec 2019	319	77	49
Jan 2020	288	42	18
Feb 2020	339	39	19
Mar 2020	343	32	30
Apr 2020	304	48	24
May 2020	302	47	37
Jun 2020	246	25	13
Jul 2020	313	39	16
Aug 2020	269	20	11
Sep 2020	311	29	15
Oct 2020	312	54	36
Nov 2020	257	47	25
Dec 2020	179	28	15
Jan 2021	299	33	15
Feb 2021	154	23	15
Mar 2021	283	63	39
Apr 2021	314	50	25
May 2021	107	40	25
Jun 2021	52	43	24
Jul 2021	48	31	12
Total	11000	1937	1109